RIFADIN rifampicin 300mg capsules blister pack - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
RIFADIN rifampicin 300mg capsules blister pack
AUST R: 233443
Active ingredients:
rifampicin

Dosage form:
Capsule

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
02 Jun 2025
to
30 Jan 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals